Results 101 to 110 of about 21,990 (200)

Editorial: Oncolytic virotherapy

open access: yesFrontiers in Molecular Biosciences, 2023
Ahmed Majeed Al-Shammari   +2 more
openaire   +3 more sources

Oncolytic viruses: how “lytic” must they be for therapeutic efficacy?

open access: yesOncoImmunology, 2019
Oncolytic viruses (OVs) preferentially target and kill cancer cells without affecting healthy cells through a multi-modal mechanism of action. While historically the direct killing activity of OVs was considered the primary mode of action, initiation or ...
Maria Eugenia Davola   +1 more
doaj   +1 more source

Supplementary Fig. S4 from Preclinical evaluation of synergistic effect of telomerase-specific oncolytic virotherapy and gemcitabine for human lung cancer

open access: yes, 2009
Supplementary Fig. S4 from Preclinical evaluation of synergistic effect of telomerase-specific oncolytic virotherapy and gemcitabine for human lung ...
Shinji Kuroda (197818)   +8 more
core   +1 more source

TGF-β Inhibition Improves Oncolytic Herpes Viroimmunotherapy in Murine Models of Rhabdomyosarcoma

open access: yesMolecular Therapy: Oncolytics, 2017
Oncolytic viruses are an emerging class of cancer therapeutics that couple cytotoxicity with the induction of an anti-tumor immune response. Host-virus interactions are complex and modulated by a tumor microenvironment whose immunosuppressive activities ...
Brian Hutzen   +8 more
doaj   +1 more source

Abstracts

open access: yesMolecular Oncology, Volume 20, Issue S1, Page 1-692, August 2026.
Abstracts submitted to the ‘EACR 2026 Congress: Innovative Cancer Science’, from 08–11 June 2026 and accepted by the Congress Organising Committee are published in this Supplement of Molecular Oncology, an affiliated journal of the European Association for Cancer Research (EACR).
wiley   +1 more source

Supplementary Fig. S3 from Preclinical evaluation of synergistic effect of telomerase-specific oncolytic virotherapy and gemcitabine for human lung cancer

open access: yes, 2009
Supplementary Fig. S3 from Preclinical evaluation of synergistic effect of telomerase-specific oncolytic virotherapy and gemcitabine for human lung ...
Shinji Kuroda (197818)   +8 more
core   +1 more source

Oncolytic viruses in cancer immunotherapy

open access: yes, 2019
Oncolytic virotherapy is a field dedicated to exploiting viruses in the battle against cancer, where their specific cytolytic effects are sorely needed. This work focuses on the mechanisms and limitations of oncolytic virotherapy, on the recent advances ...
Zupko, Jakub
core  

Oncolytic Virotherapy for Solid Tumors

open access: yes
Oncolytic viruses (OVs) are naturally occurring or genetically engineered viruses that selectively replicate in and destroy tumor cells while sparing normal tissues.
Asawa, Palash   +2 more
core   +1 more source

Emerging delivery strategy for oncolytic virotherapy

open access: yesMolecular Therapy: Oncology
Oncolytic virotherapy represents a promising approach in cancer immunotherapy. The primary delivery method for oncolytic viruses (OVs) is intratumoral injection, which apparently limits their clinical application.
Jiao Zhu   +4 more
doaj   +1 more source

Arming vaccinia virus for pancreatic cancer oncolytic virotherapy [PDF]

open access: yes, 2011
PhDVaccinia virus is a 250-300nm enveloped DNA virus from the poxvirus family and is used as a vector for oncolytic viral gene therapy. No unique cell surface receptor has been identified for Vaccinia virus and the reasons for its tropism for cancer ...
Hiley, Crispin
core  

Home - About - Disclaimer - Privacy